This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Kohei Sakanishi: Pioneering Advances in Antibody-Drug Conjugates
Introduction
Kohei Sakanishi is a notable inventor based in Tokyo, Japan. With a focus on innovative methods in biochemical production, he has made significant contributions to the field of pharmaceuticals. Sakanishi is currently affiliated with Daiichi Sankyo Company, Limited, where he applies his expertise to advance medical technologies.
Latest Patents
Sakanishi holds two patents, both centered on advancing the production of antibody-drug conjugates. His latest patent details a method for producing an antibody-drug conjugate using crystals of a compound represented by a specific formula. This innovative approach not only improves the efficiency of production but also enhances the quality of the resulting compounds. Additionally, another patent outlines a method for producing a compound that includes an intramolecular cyclization step, demonstrating Sakanishi’s commitment to advancing the science of pharmaceuticals through innovative techniques.
Career Highlights
Throughout his career, Kohei Sakanishi has remained a key figure in the pharmaceutical industry. His role at Daiichi Sankyo Company, Limited has positioned him at the forefront of pharmaceutical research and innovation. Sakanishi's patents reflect his dedication to developing new methodologies that drive clinical advancements and improve patient outcomes.
Collaborations
Sakanishi has worked alongside several esteemed colleagues, including Shigeru Noguchi and Tadahiro Takeda. These collaborations highlight the importance of teamwork in the pursuit of groundbreaking research and innovation within the pharmaceutical sector.
Conclusion
Kohei Sakanishi is an exemplary inventor whose work continues to influence the field of antibody-drug conjugates. His contributions, marked by a commitment to innovation and collaboration, underscore the critical role of inventors in shaping the future of healthcare. As the pharmaceutical industry evolves, Sakanishi’s inventions will undoubtedly pave the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile